Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-02

Clinical Trial Update: Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of LID104 for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LID104

Snippet

Sponsor: EMS | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: NOT_YET_RECRUITING